Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials-Reference-Cited by-同舟云学术

Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials

Published:2019-04-06 Issue:5 Volume:59 Page:819-824
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Hindiyeh Nada A.¹,Kellerman Donald J.²,Schmidt Peter C.²

Affiliation:

1. Stanford Headache and Facial Pain Program, Department of Neurology and Neurological Sciences Stanford University School of Medicine Stanford CA USA

2. Zosano Pharma Fremont CA USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/head.13511

Reference18 articles.

1. Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial

2. Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: Results from the International Migraine Pain Assessment Clinical Trial (IMPACT)

3. MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine

4. Sumatriptan-Naproxen for Acute Treatment of Migraine

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Most bothersome symptom in migraine and probable migraine: A population-based study;PLOS ONE;2023-11-29

2. Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trials;Headache: The Journal of Head and Face Pain;2023-10-24

3. Variation in Endpoints in FDA Medication Approvals;Neurology;2023-09-05

4. Most bothersome symptoms in patients with migraine: A hospital‐based study in Taiwan;Headache: The Journal of Head and Face Pain;2022-04-25

5. Comparing treatments in the emergency department: What works for migraine?;Headache: The Journal of Head and Face Pain;2021-04